Gynaecological Cancer

  1. Lynparza (olaparib)
    Lynparza (olaparib)
    by AstraZeneca AB
    for Breast Cancer, Gynaecological Cancer
    €6,283.20
View as Grid List

1 Item

per page
Set Descending Direction